Patents by Inventor Bernhard Teupe

Bernhard Teupe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200152335
    Abstract: A method is described herein to detect and treat hypoglycemia. An example of this method involves the detection of hypoglycemia in a patient with a computing device, computation of a recommended carbohydrate amount to ingest by the patient with the computing device in response to said detecting the hypoglycemia, output of the recommended carbohydrate amount with the computing device, and the performance of a hypoglycemia surveillance with the computing device to determine whether the recommended carbohydrate amount remedied the hypoglycemia.
    Type: Application
    Filed: January 9, 2020
    Publication date: May 14, 2020
    Applicants: Roche Diabetes Care, Inc., Roche Diagnostics International AG
    Inventors: Gilles Prodhom, Bernhard Teupe, Alan Greenburg, Maury Zivitz
  • Patent number: 10573413
    Abstract: A method is described herein to detect and treat hypoglycemia. An example of this method involves the detection of hypoglycemia in a patient with a computing device, computation of a recommended carbohydrate amount to ingest by the patient with the computing device in response to said detecting the hypoglycemia, output of the recommended carbohydrate amount with the computing device, and the performance of a hypoglycemia surveillance with the computing device to determine whether the recommended carbohydrate amount remedied the hypoglycemia.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: February 25, 2020
    Assignees: Roche Diabetes Care, Inc., Roche Diagnostics International AG
    Inventors: Gilles Prodhom, Bernhard Teupe, Alan Greenburg, Maury Zivitz
  • Patent number: 9242038
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: January 26, 2016
    Assignee: Roche Diagnostics International AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe
  • Publication number: 20140278123
    Abstract: A method is described herein to detect and treat hypoglycemia. An example of this method involves the detection of hypoglycemia in a patient with a computing device, computation of a recommended carbohydrate amount to ingest by the patient with the computing device in response to said detecting the hypoglycemia, output of the recommended carbohydrate amount with the computing device, and the performance of a hypoglycemia surveillance with the computing device to determine whether the recommended carbohydrate amount remedied the hypoglycemia.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 18, 2014
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Gilles Prodhom, Bernhard Teupe, Alan Greenburg, Maury Zivitz
  • Publication number: 20110238033
    Abstract: A diabetes therapy device is disclosed herein, which includes a profile memory storing a parameter profile and a dedicated reference time mark. The parameter profile defines at least one parameter that is associated with insulin administration as a function of time for a generally circadian chronobiological cycle. The reference time mark indicates the beginning of the circadian chronobiological cycle and initializes a running time. Insulin amounts to be administered are determined as a function of the running time in accordance with a current matching of the parameter profile. A modified matching based on the reference time mark and an upcoming trigger time is computed and is time-shifted from the current matching, wherein the modified matching is applied by making the modified matching the current matching, such that future insulin amounts to be administered are determined in accordance with the modified matching.
    Type: Application
    Filed: September 23, 2010
    Publication date: September 29, 2011
    Applicant: ROCHE DIAGNOSTICS INTERNATIONAL AG
    Inventors: Gilles Prod'hom, Thierry Prud'homme, Robert Hellwig, Bernhard Teupe